作者:Baihua Hu、Michael Malamas、John Ellingboe、Elwood Largis、Stella Han、Ruth Mulvey、Jeff Tillett
DOI:10.1016/s0960-894x(01)00147-0
日期:2001.4
investigation into the development of potent and selective human beta3 agonists, a series of thiazolidinedione analogues was prepared and evaluated for their biological activity on the human beta3-adrenergic receptor. The oxadiazolidinedione derivative 17 was found to be the most potent and selective compound in this study, with an EC50 value of 0.02 microM at the beta3 receptor, 259-fold selectivity over the beta1
作为我们对有效和选择性人β3激动剂开发的调查的一部分,制备了一系列噻唑烷二酮类似物,并评估了其对人β3肾上腺素受体的生物学活性。在本研究中发现恶二唑烷二酮衍生物17是最有效和最具选择性的化合物,在beta3受体上的EC50值为0.02 microM,在beta1受体上的选择性是259倍,在beta2受体上的选择性是745倍。